Marina Nayeli Medina-Rosales
Unidad de Investigación Biomédica de Zacatecas. Delegación Zacatecas, Instituto Mexicano del Seguro Social, IMSS, México
[ 1 ] - T Regulatory Cells Frequency During Maintenance Phase Chemotherapy for Pediatric Acute Lymphoblastic Leukemia
Background: Drugs used in cancer treatment specifically kill T regulatory cells. Objective: To determine different phenotypes of T regulatory cells during the maintenance phase chemotherapy for pediatric acute lymphoblastic leukemia (ALL). Materials: We evaluated the percentages of regulatory T cells by flow cytometry. Soluble CTLA-4 (sCTLA-4) ...
Co-Authors